Amanote Research
Register
Sign In
Article on Human Copper Transporter Ctr1 and Cisplatin
Molecular Cancer Therapeutics
- United States
doi 10.1158/1535-7163.mct-correction-a
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
May 1, 2005
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Ctr2 Regulates Biogenesis of a Cleaved Form of Mammalian Ctr1 Metal Transporter Lacking the Copper- And Cisplatin-Binding Ecto-Domain
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Structural Basis of Ion Selectivity and Permeation in the High-Affinity Copper Transporter Ctr1
Biophysical Journal
Biophysics
Organic Cation Transporter 3 Mediates Cisplatin and Copper Cross-Resistance in Hepatoma Cells
Oncotarget
Oncology
Copper Efflux Transporter (ATP7B) Contributes to the Acquisition of Cisplatin-Resistance in Human Oral Squamous Cell Lines
Oncology Reports
Medicine
Cancer Research
Oncology
Copper-Dependent Recycling of hCTR1, the Human High Affinity Copper Transporter
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Effects of Copper Supplementation on Copper Absorption, Tissue Distribution, and Copper Transporter Expression in an Infant Rat Model
American Journal of Physiology - Gastrointestinal and Liver Physiology
Hepatology
Physiology
Gastroenterology
Prognostic Value of Human Copper Transporter 1 in Patients With Cervical Cancer Treated With Concurrent Chemoradiation Therapy
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Mapping Cholesterol Binding Sites on the Human Dopamine Transporter
Biophysical Journal
Biophysics
Austria and Article 6 of the European Convention on Human Rights
European Journal of International Law
Law
International Relations
Political Science
